We are proud to be the only company in the world that combines Small RNA technology with plant stem cells to produce active ingredients for pharmaceuticals and cosmetics. “Our goal is to be listed on the stock exchange within five years,” says Yakup Bakır, CEO of ACTV Biotechnology, in an interview with Para magazine.
We have started our investment round and our goal is to accelerate our R&D activities and increase our capacity by raising 20 million TL in funding. We are a pioneer in the sector with the projects we have realized so far. Thanks to the ProliCell technology we developed with plant stem cell technology, we offer unique and effective products to the cosmetics and pharmaceutical industries. In the future, we aim to operate internationally by expanding abroad. As ACTV Biotechnology, we aim to grow with groundbreaking innovations in the pharmaceutical and cosmetics industry.
We are proud of progressing alone at the top on this path we set out as a pioneer and we are happy to improve ourselves!
Link: https://www.paradergi.com.tr/girisimcilik/2023/06/12/yerli-biyoteknoloji-firmasi-actv-vites-buyuttu